BEAMSTART Logo

HomeNews

Key diabetes drug price crashes up to 90% as generic versions launched

Business Standard LogoBusiness Standard11h ago

Key diabetes drug price crashes up to 90% as generic versions launched - Business Standard

Quick Summary:

Need More Information - write to us at assist@bsmail.

Delhi-based Mankind Pharma launched a range of empagliflozin products, including its combinations, priced between Rs 5.5 and Rs 13.5 per tablet.

The move will make the drug more accessible to India’s diabetic patients and eventually grow the market by five to six times in volume, industry insiders felt.

More Pictures

Key diabetes drug price crashes up to 90% as generic versions launched - Business Standard (Picture 1)

or

Article Details

Category: BusinessFinance

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-03-12 @ 18:49:40 (11 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 105 words

Reading Time: 1 minutes read

Sentences: 6 lines

Sentence Length: 18 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 26920493

View Article Analysis

About Business Standard

Business Standard Logo

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 278 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "Key diabetes drug price crashes up to 90% as generic versions launched" has 105 words across 6 sentences, which will take approximately 1 minutes for the average person to read.

Which news outlet covered this story?

The story "Key diabetes drug price crashes up to 90% as generic versions launched" was covered 11 hours ago by Business Standard, a news publisher based in India.

How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news.

The outlet is headquartered in India and publishes an average of 278 news stories per day.

It's most recent story was published 2 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #26920493
  • URL: https://chronographically.beamstart.com/news/key-diabetes-drug-price-crashes-17417861683924

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

Our Company

© Copyright 2025 BEAMSTART. All Rights Reserved.